|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/48 | |||
| A61K 47/02 | |||
| A61K 47/10 | |||
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61K 47/18 | |||
| A61K 47/22 | |||
| A61K 47/26 | |||
| A61K 47/32 | |||
| A61K 31/546 | |||
| A61P 31/04 |
| (11) | Patento numeris | 2988751 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14788546.1 |
| Europos patento paraiškos padavimo data | 2014-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/035454 |
| Data | 2014-04-25 |
| (87) | Numeris | WO 2014/176501 |
| Data | 2014-10-30 |
| (30) | Numeris | Data | Šalis |
| 201361815932 P | 2013-04-25 | US |
| (72) |
RADHAKRISHNAN, Balasingam, US
VAIDYA, Anuradha, US
|
| (73) |
Seachaid Pharmaceuticals, Inc.,
801 Capitola Drive Suite 5, Durham, NC 27713,
US
|
| (54) | ORAL CEFEPIME COMPOSITIONS AND USES THEREOF |
| ORAL CEFEPIME COMPOSITIONS AND USES THEREOF |